These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 21475889
1. Sann-Joong-Kuey-Jian-Tang increases the protein expression of microtubule-associated protein II light chain 3 in human colon cancer colo 205 cells. Cheng CY, Lin YH, Su CC. Mol Med Rep; 2009; 2(5):707-11. PubMed ID: 21475889 [Abstract] [Full Text] [Related]
2. Anti-tumor activity of Sann-Joong-Kuey-Jian-Tang alone and in combination with 5-fluorouracil in a human colon cancer colo 205 cell xenograft model. Cheng CY, Lin YH, Su CC. Mol Med Rep; 2010; 3(2):227-31. PubMed ID: 21472226 [Abstract] [Full Text] [Related]
3. Sann-Joong-Kuey-Jian-Tang up-regulates the protein expression of Fas and TNF-α in colo 205 cells in vivo and in vitro. Cheng CY, Lin YH, Su CC. Mol Med Rep; 2010; 3(1):63-7. PubMed ID: 21472201 [Abstract] [Full Text] [Related]
4. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Chen YL, Yan MY, Chien SY, Kuo SJ, Chen DR, Cheng CY, Su CC. Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225 [Abstract] [Full Text] [Related]
5. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of mammalian target of rapamycin but increases microtubule associated protein II light chain 3 expression to inhibit human BxPC‑3 pancreatic carcinoma cells. Su CC. Mol Med Rep; 2015 Apr; 11(4):3160-6. PubMed ID: 25516264 [Abstract] [Full Text] [Related]
6. Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl‑1 and TCTP and increases that of TNF-α and Bax in BxPC‑3 pancreatic carcinoma cells. Chien SY, Kuo SJ, Chen DR, Su CC. Int J Mol Med; 2013 Jul; 32(1):85-92. PubMed ID: 23652631 [Abstract] [Full Text] [Related]
7. Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways. Chuang WL, Su CC, Lin PY, Lin CC, Chen YL. Mol Med Rep; 2015 Aug; 12(2):1677-84. PubMed ID: 25847489 [Abstract] [Full Text] [Related]
8. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo. Su CC, Lin YH. Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785 [Abstract] [Full Text] [Related]
9. Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, Tsubura A. Anticancer Res; 2005 Dec; 25(3B):2269-76. PubMed ID: 16158974 [Abstract] [Full Text] [Related]
16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE, Wang MX, Li RQ. Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions. Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC. J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387 [Abstract] [Full Text] [Related]
18. Longan flower extract inhibits the growth of colorectal carcinoma. Hsu CP, Lin YH, Zhou SP, Chung YC, Lin CC, Wang SC. Nutr Cancer; 2010 Aug; 62(2):229-36. PubMed ID: 20099197 [Abstract] [Full Text] [Related]
19. Stable reversal of multidrug resistance in colon cancer cells by RNA interference targeting the MDR1 gene. Xia Z, Zhang L, Chen Q, Royal C, Yu Z, Liu Z, Adam BL. Mol Med Rep; 2009 Aug; 2(4):579-84. PubMed ID: 21475869 [Abstract] [Full Text] [Related]